Astigmatism Epidemiology Forecast 2025-2034

Astigmatism Epidemiology Forecast Report Coverage

Expert Market Research's “Astigmatism Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of astigmatism. It projects the future incidence and prevalence rates of astigmatism across various populations. The study covers age, gender, and type as major determinants of the astigmatism-affected population. The report highlights patterns in the prevalence of astigmatism over time and projects future trends based on multiple variables.

Astigmatism Disease Overview

Astigmatism is a common refractive error, brought on by an uneven corneal or lens curvature, which makes it difficult for light to focus correctly on the retina. This results in symptoms like headaches, eye strain, and trouble seeing at night, as well as blurred or distorted vision at all distances. It may be present from birth or develop over time, and it can coexist with nearsightedness (myopia) or farsightedness (hyperopia). Tests such as corneal curvature measurements and visual acuity evaluations are used in routine eye exams to diagnose astigmatism.

Astigmatism: Treatment Overview

Prescription eyeglasses or contact lenses that adjust for the cornea's or lens's irregular curvature can be used to treat astigmatism. Because toric contact lenses provide varying focusing powers in different eye meridians, they are specifically made to treat astigmatism. The cornea is reshaped during refractive procedures like LASIK and PRK to enhance light focusing and reduce the need for corrective lenses. In orthokeratology (Ortho-K), the cornea is temporarily reshaped for better vision during the day by wearing rigid contact lenses that have been specially made. The degree of astigmatism, lifestyle choices, and general eye health all influence the treatment option.

Epidemiology

The astigmatism epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for astigmatism by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for Astigmatism and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• A literature review found that the prevalence of astigmatism ranged from 8% to 62% in the general population, with higher rates among those aged 70 and above. While rates of oblique and against-the-rule astigmatism rose with age, with-the-rule astigmatism was more common in people 40 years of age or younger.
• A study revealed that if astigmatism is left untreated it can cause amblyopia. 13.2% of eyes with untreated astigmatism of 1.0 D or greater and less than 2.0 D were amblyopic, as were 19.6% of eyes with untreated astigmatism of 2.0 D or greater.
• In a study conducted, a dominant genetic association in astigmatism was found after analyzing 506 female British twin pairs using data from both eyes in a multivariate model. The estimated heritability for astigmatism was between 50% and 65%, which is less than the 86% quoted for myopia or hyperopia.
• A study revealed that the mean age of the patients was 42% male and 58% female. It was also reported that astigmatism was present in 40.4% of adults and 14.9% of children.

Country-wise Astigmatism Epidemiology

The astigmatism epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of astigmatism varies between countries owing to the differences in factors such as obesity, tobacco smoking, diabetes and others. A study found that the reported prevalence varied across different countries and regions in 2023, with Germany at 32%, Spain at 54%, Japan at 54%, the United States ranging from 11% to 46%, South Korea from 31% to 58%, and Northern and Western Europe at 27%. China had the highest reported prevalence of astigmatism (62%), out of all the countries/regions included in this review.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of astigmatism based on several factors.
• Astigmatism Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of astigmatism are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of astigmatism epidemiology in the 8 major markets?
• What will be the total number of patients with Astigmatism across the 8 major markets during the forecast period?
• What was the country-wise prevalence of astigmatism in the 8 major markets in the historical period?
• Which country will have the highest number of astigmatism patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of astigmatism during the forecast period of 2025-2034?
• What are the currently available treatments for astigmatism?
• What are the disease risks, signs, symptoms, and unmet needs of astigmatism?

Related Reports

Global Dry Eye Syndrome Market

Global Dry Eye Disease Treatment Market